Cellebrite DI Ltd. (CLBT) stock
Close on Nov 13, 2026Market cap $2.88BP/E 37.2Yield –
Cellebrite DI Ltd. grew revenue 18.6% to $475.68M over fiscal 2025. Operating income rose 16.8% to $66.48M, moving the operating margin from 14.2% to 14.0%. Free cash flow was $160.32M, up 29.7% from a year earlier. At the latest close the market valued the company at $2.88B, 37.2 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Jun 30, 2026
Valuation
- Market cap
- $2.88B
- P/E ratio
- 37.2
- Price to sales
- 6.05
- Price to book
- 5.34
- Dividend yield
- –
- Free cash flow yield
- 5.57%
Fundamentals
- Revenue
- $475.68M
- Net income
- $78.33M
- EPS, diluted
- $0.31
- Free cash flow
- $160.32M
Trading
- Previous close
- $10.89
- Open
- $11.00
- Day's range
- $10.88 – $11.85
- Volume
- 5,110,542
- Average volume (20 days)
- 2,059,925
- Beta (5 years)
- 0.91
- 52-week range
- $9.58 – $19.98
- RSI (14 days)
- 45.2
- Volatility (1 year)
- 63.0%
- Relative volume
- 1.93×
- WACC
- 9.7%
Market cap history
Month-end market cap since 2020, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | CLBT | S&P 500 | Difference | CLBT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +1.3% | -3.0% | +4.4 pts | ||
| 3 months | +6.8% | -2.8% | +9.5 pts | ||
| Year to date | -36.1% | +11.5% | −47.5 pts | ||
| 1 year | -40.2% | +13.5% | −53.7 pts | ||
| 3 years | +52.9% | +77.7% | −24.8 pts | +15.2% | +21.1% |
| 5 years | +8.1% | +72.6% | −64.5 pts | +1.6% | +11.5% |
Eight years at a glance
Fiscal years 2018 to 2025, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Cellebrite DI filed with the SEC as exhibits to Form 8-K or 6-K
About Cellebrite DI
Services-Prepackaged Software
Cellebrite DI Ltd. develops and provides digital investigative and intelligence software solutions. The company's core platform encompasses digital forensics software, such as the Inseyets suite, which enables lawful data extraction and decoding from mobile devices, computers, and cloud sources. It also offers digital investigations and analytics platforms, including Guardian Forensics for evidence management, Guardian Collaborate, and Pathfinder for pattern identification and relationship mapping. In addition, through its Corellium offering, the company provides virtualization software for vulnerability research and penetration testing, alongside training, certification, and lab services. Its software serves public sector entities—including law enforcement, defense, and intelligence agencies—as well as private sector enterprises and service providers handling corporate investigations and cybersecurity.
Company profile, executives and historyCellebrite DI stock: common questions
What is Cellebrite DI's stock price?
CLBT closed at $11.53 on Nov 13, 2026, up 5.88% on the day. Over the past 52 weeks it traded between $9.58 and $19.98.
What is Cellebrite DI's market cap?
Cellebrite DI was worth $2.88B at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
What is CLBT's P/E ratio?
CLBT trades at 37.2 times earnings, based on diluted earnings per share of $0.31 over fiscal 2025.
How much revenue does Cellebrite DI make?
Cellebrite DI reported revenue of $475.68M for fiscal 2025, up 18.6% from a year earlier.
Does Cellebrite DI pay a dividend?
No. Cellebrite DI has not paid a cash dividend over the last twelve months.
How has CLBT stock performed over the past year?
Including dividends, CLBT returned -40.2% over the past year, against +13.5% for the S&P 500.
How many CLBT shares are sold short?
6M shares were sold short at the latest FINRA report, 2.43% of the float, or 4.3 days of average trading volume.
Who are Cellebrite DI's competitors?
Companies most similar to Cellebrite DI by business, industry and size include CGNT, FROG, RPD, CCSI, RMTHF.
See a number that looks wrong?